Disease risk scores for skin cancers

被引:0
|
作者
Pierre Fontanillas
Babak Alipanahi
Nicholas A. Furlotte
Michaela Johnson
Catherine H. Wilson
Steven J. Pitts
Robert Gentleman
Adam Auton
机构
[1] 23andMe Inc.,
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
We trained and validated risk prediction models for the three major types of skin cancer— basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma—on a cross-sectional and longitudinal dataset of 210,000 consented research participants who responded to an online survey covering personal and family history of skin cancer, skin susceptibility, and UV exposure. We developed a primary disease risk score (DRS) that combined all 32 identified genetic and non-genetic risk factors. Top percentile DRS was associated with an up to 13-fold increase (odds ratio per standard deviation increase >2.5) in the risk of developing skin cancer relative to the middle DRS percentile. To derive lifetime risk trajectories for the three skin cancers, we developed a second and age independent disease score, called DRSA. Using incident cases, we demonstrated that DRSA could be used in early detection programs for identifying high risk asymptotic individuals, and predicting when they are likely to develop skin cancer. High DRSA scores were not only associated with earlier disease diagnosis (by up to 14 years), but also with more severe and recurrent forms of skin cancer.
引用
收藏
相关论文
共 50 条
  • [31] Use of disease risk scores in pharmacoepidemiologic studies
    Arbogast, Patrick G.
    Ray, Wayne A.
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2009, 18 (01) : 67 - 80
  • [32] Risk Scores in Valvular Heart Disease Interventions
    Casalino, Ricardo
    Tarassoutchi, Flavio
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2012, 98 (05) : E84 - E86
  • [33] Polygenic risk scores in coronary artery disease
    Christiansen, Morten Krogh
    Nyegaard, Mette
    Jensen, Henrik Kjaerulf
    CURRENT OPINION IN CARDIOLOGY, 2023, 38 (01) : 39 - 46
  • [34] Cardiovascular Disease Risk Prediction Models and Scores
    Giannakoulas, George
    Doundoulakis, Ioannis
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (10) : 1231 - 1231
  • [35] Polygenic Risk Scores for Coronary Heart Disease
    Khan, Sadiya S.
    Pencina, Michael J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (01): : 32 - 33
  • [36] Polygenic risk scores in coronary artery disease
    Rao, Abhiram S.
    Knowles, Joshua W.
    CURRENT OPINION IN CARDIOLOGY, 2019, 34 (04) : 435 - 440
  • [37] A Review of Disease Risk Scores and Their Application in Pharmacoepidemiology
    Richard Wyss
    Robert J. Glynn
    Joshua J. Gagne
    Current Epidemiology Reports, 2016, 3 (4) : 277 - 284
  • [38] Polygenic risk scores in familial Alzheimer disease
    Tosto, Giuseppe
    Bird, Thomas D.
    Tsuang, Debby
    Bennett, David A.
    Boeve, Bradley F.
    Cruchaga, Carlos
    Faber, Kelley
    Foroud, Tatiana M.
    Farlow, Martin
    Goate, Alison M.
    Bertlesen, Sarah
    Graff-Radford, Neill R.
    Medrano, Martin
    Lantigua, Rafael
    Manly, Jennifer
    Ottman, Ruth
    Rosenberg, Roger
    Schaid, Daniel J.
    Schupf, Nicole
    Stern, Yaakov
    Sweet, Robert A.
    Mayeux, Richard
    NEUROLOGY, 2017, 88 (12) : 1180 - 1186
  • [39] Risk Scores in Patients with Chronic Kidney Disease
    Schneider, Markus P.
    Eckardt, Kai-Uwe
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (11) : 739 - 742
  • [40] Polygenic risk scores for the prediction of cardiometabolic disease
    O'Sullivan, Jack W.
    Ashley, Euan A.
    Elliott, Perry M.
    EUROPEAN HEART JOURNAL, 2023, 44 (02) : 89 - 99